$29.70
-0.085-0.29%
Last update: Nov 9, 9:32 AM
Vera Therapeutics Inc
VERANASDAQ
The average analyst price target for Vera Therapeutics is $64.06, 115.7% above the current price. Of 15 analysts, 13 rate it Buy and 2 Hold. Targets range from $25 to $100. The latest change came on Nov 6, 2026, when Wedbush lowered its price target on Vera Therapeutics from $34 to $29 and kept a Neutral rating.
Price Target Range — 13 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
